Workflow
心血管医疗
icon
Search documents
第九届沪鲁心血管病专家论坛在日照开幕
Qi Lu Wan Bao Wang· 2025-09-28 05:04
山东第一医科大学附属省立医院吴向东书记在致辞中表示,九年来,沪鲁心血管病专家论坛已成为真正有水平的有规模的精品学术盛会。相信本次大会将 继续秉承继承、创新、合作和培育的核心价值观,以开阔的视野走在医疗品质的最前沿,走在学术创新的最尖端,也走在全球合作的最热点,走在培育人 才的第一线。 预祝本次的相聚能共同为医学事业的进步添上浓墨重彩的一笔,为护佑人民健康,为健康山东、健康中国建设添砖加瓦。 9月27日上午,第九届沪鲁心血管病专家论坛暨山东省医学会第十一次介入心血管病学术会议、第五次心力衰竭多学科学术会议、第八届日照心血管峰 会、2025长海心血管病介入治疗新进展高峰论坛、第二十一届冠状动脉慢性闭塞病变介入治疗学会议(CTOCC2025)及CCI第十期创新学院第一站会议在日 照开幕。 中国科学院院士、青岛大学附属日照医院/日照心脏病医院院长葛均波教授,北京大学第一医院心内科首席专家霍勇教授、山东第一医科大学附属省立医 院党委书记吴向东等来自全国心血管领域众多权威专家、市政府相关领导出席开幕式。 大会执行主席、山东第一医科大学附属省立医院心内科主任苑海涛教授主持仪式。 CTOCC2025期间,国内外顶尖专家齐聚日 ...
直播预告:立足技术创新与学科协同 打造“心”高地
Ren Min Wang· 2025-07-01 02:22
Group 1 - The core idea of the news is to promote the experiences and innovative practices of public hospitals in China, enhancing the quality of healthcare services and allowing the public to feel the benefits of medical reforms [1] - A series of live broadcasts titled "Hospital Directors Talk" will feature hospital directors from across the country sharing their insights and experiences [1] - The first episode will take place on July 2, featuring Hou Xumin, the director of Shanghai Chest Hospital, and Li Ruogu, the head of the cardiology department, discussing "Technological Innovation and Collaborative Disciplines" [1] Group 2 - Hou Xumin holds multiple prestigious positions, including Vice President of Shanghai Chest Hospital and various leadership roles in medical associations, showcasing his expertise in cardiology [4] - Li Ruogu is also a prominent figure in the field, serving as the head of the cardiology department and holding significant academic and editorial positions [4] Group 3 - The live broadcast can be accessed through the People's Good Doctor App, specifically in the "Famous Doctor Live" section [5] - Viewers can also follow the People's Health public WeChat account for additional health-related content and instructions on downloading the app [6]
《北京市心血管内科质量控制和改进中心质控报告(2024年)》发布
Zhong Guo Jing Ji Wang· 2025-06-24 14:18
Core Insights - The report indicates a significant improvement in the intervention treatment mortality rate for coronary heart disease in Beijing, dropping from 0.10% in 2023 to 0.01% in 2024, marking a historical low [1] - The median D2W time for acute ST-segment elevation myocardial infarction patients has decreased to 57 minutes in 2024, a reduction of 10 minutes from 2022, with 94.9% of cases achieving D2W time under 90 minutes, an increase of 10.8 percentage points from 2022 [1] Group 1 - The Beijing Cardiovascular Internal Medicine Quality Control and Improvement Center analyzed 536 adverse outcome cases in 2024, leading to optimized rescue processes across multiple hospitals, effectively reducing medical risks [2] - The collaborative rescue network in Beijing has been upgraded to cover 65 medical institutions, supported by 11 district-level quality control centers to enhance quality control at the district level [2] - The center aims to achieve homogenization and high-quality development in cardiovascular disease diagnosis and treatment, focusing on specialized training, quality monitoring, and the promotion of information technology tools [2]